Article

Meet me at the movie on Tuesday, April 9

Author(s):

Kathy LaTour blog image

For those of you near Dallas, come on into town next Tuesday evening for the second national showing of Decoding Annie Parker at the Angelika theater at Mockingbird Station. The movie starts at 7:30 and director Steven Bernstein will be on site. The national premiere took place in New York City on April 1. This is the true story of geneticist Mary Claire King and Canadian breast cancer survivor Anne Parker, who both spent years fighing their own communities to convince them that breast cancer had a genetic component. As we all know, King's work resulted in identification of the BRCA1 and 2 genes. Parker was the first woman in Canada to get the test after losing her mother and sister to breast cancer and going through her own battle with the disease. You can get tickets for the movie at the website for the film festival and I'll see you there.

Related Videos
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
1 expert is featured in this series.
Dr. Richard “Rick" Winneker
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
1 expert is featured in this series.
Related Content